Amino-Terminal Pro-B-Type Natriuretic Peptide Testing to Assist the Diagnostic Evaluation of Heart Failure in Symptomatic Primary Care Patients

American Journal of Cardiology

Volumn 101, Issue 3 SUPPL., 2008, Pages

  Hildebrandt, Per ^a   Collinson, Paul O ^b  

^a ROSKILDE HOSPITAL   (Denmark)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DYSPNEA; HEART FAILURE; HUMAN; PREDICTOR VARIABLE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY ANALYSIS;

BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; OUTPATIENTS; PEPTIDE FRAGMENTS; PRIMARY HEALTH CARE; PROGNOSIS; PROTEIN PRECURSORS; SEVERITY OF ILLNESS INDEX;

EID: 38649117584     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.11.016     Document Type: Article

References (15)

1. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., Tavazzi L., Smiseth O.A., Gavazzi A., Haverich A., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
2. Al-Barjas M., Nair D., Ayrton P., Morris R., and Davar J. How can the role of N-terminal pro B natriuretic peptide (NT-proBNP) be optimised in heart failure screening?. A prospective observational comparative study. [abstract]. Eur J Heart Fail 3 suppl 1 (2004) 223
3. Fuat A., Murphy J.J., Hungin A.P., Curry J., Mehrzad A.A., Hetherington A., Johnston J.I., Smellie W.S., Duffy V., and Cawley P. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract 56 (2006) 327-333
4. Gustafsson F., Badskjaer J., Steensgaard-Hansen F., Poulsen A.H., and Hildebrandt P. Value of N-proBNP in the diagnosis of left ventricular systolic dysfunction in primary care patients referred for echocardiography. Heart Drug 3 (2003) 141-146
5. Gustafsson F., Steensgaard-Hansen F., Badskjaer J., Poulsen A.H., Corell P., and Hildebrandt P. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail 11 (2005) S15-S20
6. Nielsen L.S., Svanegaard J., Klitgaard N.A., and Egeblad H. N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea. Eur J Heart Fail 6 (2004) 63-70
7. Zaphiriou A., Robb S., Murray-Thomas T., Mendez G., Fox K., McDonagh T., Hardman S.M., Dargie H.J., and Cowie M.R. The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur J Heart Fail 7 (2005) 537-541
8. Wright S.P., Doughty R.N., Pearl A., Gamble G.D., Whalley G.A., Walsh H.J., Gordon G., Bagg W., Oxenham H., Yandle T., Richards M., and Sharpe N. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol 42 (2003) 1793-1800
9. Lim T.K., Collinson P.O., Celik E., Gaze D., and Senior R. Value of primary care electrocardiography for the prediction of left ventricular systolic dysfunction in patients with suspected heart failure. Int J Cardiol 115 (2007) 73-74
10. Tschope C., Kasner M., Westermann D., Gaub R., Poller W.C., and Schultheiss H.P. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J 26 (2005) 2277-2284
11. Heidenreich P.A., Gubens M.A., Fonarow G.C., Konstam M.A., Stevenson L.W., and Shekelle P.G. Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction. J Am Coll Cardiol 43 (2004) 1019-1026
12. Collinson P.O. The cost effectiveness of B-Type natriuretic peptide measurement in the primary care setting-a UK perspective. Congest Heart Fail 12 (2006) 103-107
13. Masson S., and Latini R. Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure. Am J Cardiol 101 (2008) 56A-60A
14. Raymond I., Groenning B.A., Hildebrandt P.R., Nilsson J.C., Baumann M., Trawinski J., and Pedersen F. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 89 (2003) 745-751
15. Costello-Boerrigter L.C., Boerrigter G., Redfield M.M., Rodeheffer R.J., Urban L.H., Mahoney D.W., Jacobsen S.J., Heublein D.M., and Burnett Jr. J.C. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 345-353